Goldman Sachs’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-75,233
Closed -$4.42M 5020
2023
Q4
$4.42M Buy
75,233
+40,234
+115% +$2.36M ﹤0.01% 2687
2023
Q3
$1.52M Sell
34,999
-6,156
-15% -$268K ﹤0.01% 3271
2023
Q2
$1.49M Sell
41,155
-6,607
-14% -$239K ﹤0.01% 3379
2023
Q1
$1.78M Sell
47,762
-244,936
-84% -$9.11M ﹤0.01% 3295
2022
Q4
$13.3M Buy
292,698
+74,440
+34% +$3.37M ﹤0.01% 1909
2022
Q3
$15.2M Sell
218,258
-2,229,202
-91% -$156M ﹤0.01% 1799
2022
Q2
$164M Buy
2,447,460
+2,318,853
+1,803% +$156M 0.04% 421
2022
Q1
$10.6M Sell
128,607
-104,492
-45% -$8.59M ﹤0.01% 2192
2021
Q4
$34.2M Buy
233,099
+36,903
+19% +$5.41M 0.01% 1372
2021
Q3
$34.7M Buy
196,196
+17,692
+10% +$3.13M 0.01% 1329
2021
Q2
$28.8M Sell
178,504
-234,935
-57% -$37.9M 0.01% 1469
2021
Q1
$70.8M Sell
413,439
-64,561
-14% -$11.1M 0.02% 793
2020
Q4
$105M Sell
478,000
-82,103
-15% -$18M 0.03% 509
2020
Q3
$93M Buy
560,103
+181,261
+48% +$30.1M 0.03% 533
2020
Q2
$43.3M Sell
378,842
-66,488
-15% -$7.59M 0.01% 950
2020
Q1
$34.2M Buy
445,330
+124,044
+39% +$9.54M 0.01% 1009
2019
Q4
$41.4M Sell
321,286
-30,864
-9% -$3.98M 0.01% 1148
2019
Q3
$27.4M Buy
352,150
+66,009
+23% +$5.14M 0.01% 1340
2019
Q2
$29.5M Sell
286,141
-19,688
-6% -$2.03M 0.01% 1348
2019
Q1
$22.4M Buy
305,829
+228,312
+295% +$16.7M 0.01% 1542
2018
Q4
$3.29M Sell
77,517
-19,092
-20% -$810K ﹤0.01% 2575
2018
Q3
$4.55M Buy
96,609
+49,315
+104% +$2.32M ﹤0.01% 2487
2018
Q2
$2.33M Sell
47,294
-123,015
-72% -$6.06M ﹤0.01% 2822
2018
Q1
$5.23M Buy
170,309
+137,901
+426% +$4.23M ﹤0.01% 2317
2017
Q4
$591K Buy
+32,408
New +$591K ﹤0.01% 3378
2017
Q3
Sell
-98,251
Closed -$359K 4450
2017
Q2
$359K Buy
98,251
+87,858
+845% +$321K ﹤0.01% 3708
2017
Q1
$54K Buy
+10,393
New +$54K ﹤0.01% 4207
2016
Q4
Sell
-68,076
Closed -$450K 4593
2016
Q3
$450K Buy
68,076
+30,914
+83% +$204K ﹤0.01% 3499
2016
Q2
$203K Buy
+37,162
New +$203K ﹤0.01% 3852
2015
Q1
Sell
-27,295
Closed -$506K 4660
2014
Q4
$506K Sell
27,295
-9,390
-26% -$174K ﹤0.01% 3353
2014
Q3
$642K Sell
36,685
-13,164
-26% -$230K ﹤0.01% 3180
2014
Q2
$997K Buy
49,849
+21,402
+75% +$428K ﹤0.01% 2967
2014
Q1
$542K Buy
28,447
+1,600
+6% +$30.5K ﹤0.01% 3326
2013
Q4
$446K Sell
26,847
-7,300
-21% -$121K ﹤0.01% 3483
2013
Q3
$517K Buy
+34,147
New +$517K ﹤0.01% 3315